• Info
  • Insider Ownership

Insider Trading & Ownership of Sean Smith

Location
Seattle, WA
Summary
The estimated net worth of Sean Smith is at least $14,990 dollars as of 14 Aug 2023. Sean Smith is the Interim CFO, Prin Acct Off of Neoleukin Therapeutics, Inc. and owns shares of Neurogene Inc. (NGNE) stock worth about $15K.
Signature
/s/ Sean Smith
All Insider Reports
All Insider Reports

Notify me when Sean Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Sean Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NGNE Neoleukin Therapeutics, Inc. Interim CFO, Prin Acct Off $14,990 10 Aug 2023

Insider Transactions Reported by Sean Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.